NXS 3.70% 28.0¢ next science limited

re-read the december quarterly

  1. 1,137 Posts.
    Given some of the concerns aired on this thread regarding the future of Nxs in light of Longtom issues, I had a re-read of the December quarterly issued only 7 weeks ago.

    In summary

    Longtom producing well- revenues of 28.6 million ytd.
    Longtom 5 travelling well
    Echuca scholes progressing
    Crux partnership going well
    Cashflow good
    Admin costs good

    And so on.

    I dont think this Longtom issue is going to have much impact. It was out for 3 months last year so we have been through this before. Cash balance up 3m for quarter and interests costs based on current financing under control.

    Doesnt read like a company on a knife edge. No divestment at the moment, longtom down but otherwise travelling fine and meeting strategic objectives.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
28.0¢
Change
0.010(3.70%)
Mkt cap ! $81.67M
Open High Low Value Volume
27.0¢ 28.0¢ 25.0¢ $70.19K 259.0K

Buyers (Bids)

No. Vol. Price($)
1 50000 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 10321 1
View Market Depth
Last trade - 15.56pm 18/07/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.